resveratrol has been researched along with Myotonic Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rewashdy, A; Bélanger, G; Jasmin, BJ; Ravel-Chapuis, A | 1 |
| Lee, T; Matsuo, M; Nishida, A; Takarada, T; Takeshima, Y; Takeuchi, A | 1 |
2 other study(ies) available for resveratrol and Myotonic Dystrophy
| Article | Year |
|---|---|
Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Disease Models, Animal; Humans; Mice; Motor Activity; Muscle, Skeletal; Myoblasts; Myotonic Dystrophy; Protein Kinases; Resveratrol; Ribonucleotides; RNA-Binding Proteins; RNA, Messenger; Trinucleotide Repeat Expansion | 2018 |
Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts.
Topics: Exons; Fibroblasts; HeLa Cells; Humans; Myotonic Dystrophy; Protein Splicing; Receptor, Insulin; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Up-Regulation | 2015 |